UNSPSC 51183703: Pioglitazone

This classification denotes an anti-diabetic agent with the molecular formula C19H20N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) X4OV71U42S, chemically known as 2,4-thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)- but more generally known as pioglitazone, which bears US NIH Compound Identifier 4829. European Medicines Agency schedules Pioglitazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09857MIG.

UNSPSC 51183703 Pioglitazone, a Commodity code, covers pharmaceutical products procured by state and local health systems, departments of health, and multistate cooperative purchasing alliances. The work involves supplying generic pharmaceuticals and over-the-counter products through authorized drug wholesalers to state and local government facilities. Solicitations require vendors to provide comprehensive product information including National Drug Codes, SKUs, and UPCs; maintain compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act; hold contractual relationships with specified authorized wholesalers; and offer pricing flexibility through multiple formats such as flat price, net price variants, or WAC-minus structures. Insurance requirements typically include commercial general liability of at least $5,000,000 per occurrence and professional liability coverage. Products must meet FDA requirements and possess a minimum one-year expiration date from manufacture with a six-month shelf life remaining.

The Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products serving participating state and local government facilities across Minnesota and Oregon, with proposals due March 26, 2026. The MMCAP solicitation uses ePro for submissions with pricing and product data submitted as CSV-formatted Excel spreadsheets; evaluations are weighted 75 percent on price competitiveness, 10 percent on fixed pricing for the contract term, 5 percent each on administrative fee format compliance, EDI capability, and agreement to a 3 percent administrative fee. Contract terms run two years for new responders with optional MMCAP extensions, while incumbent amendments align through June 30, 2028. Awarded vendors will be provided to authorized wholesalers by May 15, 2026, with contracts effective July 1, 2026.